1. Home
  2. UG vs OCX Comparison

UG vs OCX Comparison

Compare UG & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • OCX
  • Stock Information
  • Founded
  • UG 1942
  • OCX 2009
  • Country
  • UG United States
  • OCX United States
  • Employees
  • UG N/A
  • OCX N/A
  • Industry
  • UG Package Goods/Cosmetics
  • OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • UG Consumer Discretionary
  • OCX Health Care
  • Exchange
  • UG Nasdaq
  • OCX Nasdaq
  • Market Cap
  • UG 43.9M
  • OCX 38.7M
  • IPO Year
  • UG N/A
  • OCX N/A
  • Fundamental
  • Price
  • UG $9.55
  • OCX $2.61
  • Analyst Decision
  • UG
  • OCX Buy
  • Analyst Count
  • UG 0
  • OCX 3
  • Target Price
  • UG N/A
  • OCX $4.42
  • AVG Volume (30 Days)
  • UG 19.4K
  • OCX 64.0K
  • Earning Date
  • UG 11-08-2024
  • OCX 11-12-2024
  • Dividend Yield
  • UG 6.28%
  • OCX N/A
  • EPS Growth
  • UG 38.11
  • OCX N/A
  • EPS
  • UG 0.76
  • OCX N/A
  • Revenue
  • UG $12,312,275.00
  • OCX $709,000.00
  • Revenue This Year
  • UG N/A
  • OCX N/A
  • Revenue Next Year
  • UG N/A
  • OCX $167.93
  • P/E Ratio
  • UG $12.59
  • OCX N/A
  • Revenue Growth
  • UG 11.51
  • OCX N/A
  • 52 Week Low
  • UG $6.75
  • OCX $2.29
  • 52 Week High
  • UG $16.25
  • OCX $4.34
  • Technical
  • Relative Strength Index (RSI)
  • UG 24.16
  • OCX 30.23
  • Support Level
  • UG $9.00
  • OCX $2.73
  • Resistance Level
  • UG $10.65
  • OCX $3.04
  • Average True Range (ATR)
  • UG 0.84
  • OCX 0.14
  • MACD
  • UG -0.32
  • OCX -0.03
  • Stochastic Oscillator
  • UG 10.68
  • OCX 0.00

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About OCX Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.

Share on Social Networks: